Nanoveu Ltd’s (ASX:NVU) chairman and chief executive Alfred Chong discusses with Proactive's Andrew Scott their antiviral protective screens and cases for tablets and smartphones.
He says the nanotechnology incorporated within them has proven to be effective against viruses and bacteria such as influenza-A and E. coli and they're currently undergoing testing to see if they can protect against COVID-19.
The plan is to have them available and on sale around June/July this year.
Price: 0.063 AUD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Nanoveu Ltd named herein, including the promotion by the Company of Nanoveu Ltd in any Content on the Site, the Company receives from said...
FOR OUR FULL DISCLAIMER CLICK HERE
Nanoveu Ltd's (ASX:NVU) Alfred Chong caught up with Proactive's Andrew Scott after completing what they describe as a revolutionary advanced prototype of its EyeFyx product. It's designed to correct farsightedness for people using digital devices without the need for glasses. The company has...
